State Street
VMD icon

State Street’s Viemed Healthcare VMD Stock Holding History

State Street’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.69M Buy
762,097
+19,138
+3% +$190K ﹤0.01% 2754
2026
Q1 		$6.84M Buy
742,959
+67,769
+10% +$564K ﹤0.01% 2804
2025
Q4 		$5.02M Buy
675,190
+11,385
+2% +$78K ﹤0.01% 2992
2025
Q3 		$4.51M Buy
663,805
+4,257
+0.6% +$28.8K ﹤0.01% 3028
2025
Q2 		$4.56M Buy
659,548
+35,373
+6% +$240K ﹤0.01% 2987
2025
Q1 		$4.54M Sell
624,175
-6,687
-1% -$52.5K ﹤0.01% 2920
2024
Q4 		$5.06M Buy
630,862
+26,066
+4% +$226K ﹤0.01% 2972
2024
Q3 		$4.43M Sell
604,796
-32,378
-5% -$231K ﹤0.01% 3021
2024
Q2 		$4.17M Buy
637,174
+33,639
+6% +$253K ﹤0.01% 3003
2024
Q1 		$5.69M Buy
603,535
+143,753
+31% +$1.23M ﹤0.01% 2874
2023
Q4 		$3.61M Buy
459,782
+19,550
+4% +$142K ﹤0.01% 3098
2023
Q3 		$2.96M Buy
440,232
+4,674
+1% +$38.3K ﹤0.01% 3158
2023
Q2 		$4.26M Buy
+435,558
New +$4.42M ﹤0.01% 3074
2022
Q2 		– Sell
-514,807
Closed -$2.56M – 4976
2022
Q1 		$2.56M Buy
514,807
+62
+0% +$288 ﹤0.01% 3474
2021
Q4 		$2.69M Sell
514,745
-3,941
-0.8% -$22K ﹤0.01% 3545
2021
Q3 		$2.88M Buy
518,686
+1,851
+0.4% +$12K ﹤0.01% 3511
2021
Q2 		$3.69M Sell
516,835
-11,675
-2% -$101K ﹤0.01% 3378
2021
Q1 		$5.35M Sell
528,510
-34,306
-6% -$323K ﹤0.01% 3021
2020
Q4 		$4.37M Buy
562,816
+114,845
+26% +$1.01M ﹤0.01% 3029
2020
Q3 		$3.87M Buy
447,971
+34,237
+8% +$345K ﹤0.01% 2907
2020
Q2 		$3.97M Buy
+413,734
New +$3.22M ﹤0.01% 2874

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

State Street's VMD Position: Q2 2026 in Review

State Street increased its Viemed Healthcare (VMD) stake by 2.6% in Q2 2026, buying an estimated $190K and bringing the position to 762,097 shares worth $8.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

State Street first reported a position in VMD in Q2 2020 and has held it in 21 quarters since. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • State Street held 762,097 shares of Viemed Healthcare worth $8.69M as of Q2 2026.
  • State Street bought 19,138 Viemed Healthcare shares in Q2 2026, an estimated $190K.
  • Viemed Healthcare made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2754 holding.
  • State Street first reported a position in Viemed Healthcare in Q2 2020 and has held it in 21 quarters since.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.